NEW YORK, April 30 - Nanogen has appointed Gerald Wills, formerly the chief
financial officer of Trega Biosciences, as its vice president and chief financial officer, the San Diego-based company said Monday.

Wills, 48, will replace the current CFO Kieran Gallahue, who will now work solely as president of Nanogen.

Wills served in his position at Trega from 1999 until it was acquired by Lion Biosciences in March. Previously, Wills was chief financial officer of cardiac testing biotech company Molecular Biosystems.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.